Trial intelligence / Profile preview

Artefenomel + Piperaquine in Uncomplicated Malaria

NCT02083380Phase 3Completed

Sponsor
Medicines for Malaria Venture
Start
Jul 2014
Primary completion
Oct 2015
Modality
Small Molecules
Countries
7
01

Overview

A Phase 3 trial of artefenomel in Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Jul 2014; status: completed.

02

Drugs

artefenomel
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT02083380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02083380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call